Cargando…

Buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice

Gut microbiota regulate the neurodevelopmental processes and brain functions through the regulation of the microbiota–gut interaction and gut–brain communication. Buspirone, an agonist for serotonin 5-HT1A receptors, is used for the treatment of anxiety/depression. Therefore, to understand the gut m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jeon-Kyung, Han, Sang-Kap, Joo, Min-Kyung, Kim, Dong-Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969772/
https://www.ncbi.nlm.nih.gov/pubmed/33731795
http://dx.doi.org/10.1038/s41598-021-85681-w
_version_ 1783666294639296512
author Kim, Jeon-Kyung
Han, Sang-Kap
Joo, Min-Kyung
Kim, Dong-Hyun
author_facet Kim, Jeon-Kyung
Han, Sang-Kap
Joo, Min-Kyung
Kim, Dong-Hyun
author_sort Kim, Jeon-Kyung
collection PubMed
description Gut microbiota regulate the neurodevelopmental processes and brain functions through the regulation of the microbiota–gut interaction and gut–brain communication. Buspirone, an agonist for serotonin 5-HT1A receptors, is used for the treatment of anxiety/depression. Therefore, to understand the gut microbiota-mediated mechanism of buspirone on anxiety/depression, we examined its effect on the immobilization stress (IS) or Escherichia coli K1 (EC)-induced anxiety/depression in mice. Oral or intraperitoneal administration of buspirone significantly suppressed stressor-induced anxiety/depression-like behaviors in the elevated plus maze, light/dark transition, tail suspension, and forced swimming tasks. Their treatments also reduced TNF-α expression and NF-κB(+)/Iba1(+) cell population in the hippocampus and myeloperoxidase activity and NF-κB(+)/CD11c(+) cell population in the colon. Buspirone treatments partially restored IS- or EC-induced gut microbiota perturbation such as β-diversity to those of normal control mice: they reduced the IS- or EC-induced gut Proteobacteria population. In particular, the anxiolytic activity of buspirone was positively correlated with the populations of Bacteroides and PAC001066_g in EC- or IS-exposed mice, while the populations of Lachnospiraceae, KE159660_g, LLKB_g, Helicobacter, and PAC001228_g were negatively correlated. The anti-depressant effect of buspirone was positively correlated with the Roseburia population. The fecal microbiota transplantations from buspirone-treated mice with IS-induced anxiety/depression or normal control mice suppressed IS-induced anxiety/depression-like behaviors and reduced hippocampal NF-κB(+)/Iba1(+) and colonic NF-κB(+)/CD11c(+) cell populations in the transplanted mice. Furthermore, they modified IS-induced perturbation of gut microbiota composition, particularly Proteobacteria, in the transplanted mice. In conclusion, buspirone alleviates IS as well as EC-induced anxiety/depression and colitis. It also suppresses associated neuroinflammation and modulates gut microbiota. Future studies can help to explain the relationship, if any, in the central and peripheral effects of buspirone.
format Online
Article
Text
id pubmed-7969772
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79697722021-03-19 Buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice Kim, Jeon-Kyung Han, Sang-Kap Joo, Min-Kyung Kim, Dong-Hyun Sci Rep Article Gut microbiota regulate the neurodevelopmental processes and brain functions through the regulation of the microbiota–gut interaction and gut–brain communication. Buspirone, an agonist for serotonin 5-HT1A receptors, is used for the treatment of anxiety/depression. Therefore, to understand the gut microbiota-mediated mechanism of buspirone on anxiety/depression, we examined its effect on the immobilization stress (IS) or Escherichia coli K1 (EC)-induced anxiety/depression in mice. Oral or intraperitoneal administration of buspirone significantly suppressed stressor-induced anxiety/depression-like behaviors in the elevated plus maze, light/dark transition, tail suspension, and forced swimming tasks. Their treatments also reduced TNF-α expression and NF-κB(+)/Iba1(+) cell population in the hippocampus and myeloperoxidase activity and NF-κB(+)/CD11c(+) cell population in the colon. Buspirone treatments partially restored IS- or EC-induced gut microbiota perturbation such as β-diversity to those of normal control mice: they reduced the IS- or EC-induced gut Proteobacteria population. In particular, the anxiolytic activity of buspirone was positively correlated with the populations of Bacteroides and PAC001066_g in EC- or IS-exposed mice, while the populations of Lachnospiraceae, KE159660_g, LLKB_g, Helicobacter, and PAC001228_g were negatively correlated. The anti-depressant effect of buspirone was positively correlated with the Roseburia population. The fecal microbiota transplantations from buspirone-treated mice with IS-induced anxiety/depression or normal control mice suppressed IS-induced anxiety/depression-like behaviors and reduced hippocampal NF-κB(+)/Iba1(+) and colonic NF-κB(+)/CD11c(+) cell populations in the transplanted mice. Furthermore, they modified IS-induced perturbation of gut microbiota composition, particularly Proteobacteria, in the transplanted mice. In conclusion, buspirone alleviates IS as well as EC-induced anxiety/depression and colitis. It also suppresses associated neuroinflammation and modulates gut microbiota. Future studies can help to explain the relationship, if any, in the central and peripheral effects of buspirone. Nature Publishing Group UK 2021-03-17 /pmc/articles/PMC7969772/ /pubmed/33731795 http://dx.doi.org/10.1038/s41598-021-85681-w Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Kim, Jeon-Kyung
Han, Sang-Kap
Joo, Min-Kyung
Kim, Dong-Hyun
Buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice
title Buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice
title_full Buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice
title_fullStr Buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice
title_full_unstemmed Buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice
title_short Buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice
title_sort buspirone alleviates anxiety, depression, and colitis; and modulates gut microbiota in mice
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7969772/
https://www.ncbi.nlm.nih.gov/pubmed/33731795
http://dx.doi.org/10.1038/s41598-021-85681-w
work_keys_str_mv AT kimjeonkyung buspironealleviatesanxietydepressionandcolitisandmodulatesgutmicrobiotainmice
AT hansangkap buspironealleviatesanxietydepressionandcolitisandmodulatesgutmicrobiotainmice
AT joominkyung buspironealleviatesanxietydepressionandcolitisandmodulatesgutmicrobiotainmice
AT kimdonghyun buspironealleviatesanxietydepressionandcolitisandmodulatesgutmicrobiotainmice